Eikon Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 5.31 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 287.62M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent W...